Plexus Corporation (PLXS) reported mixed fourth quarter 2011 financial results. The company beat the Zacks Consensus Estimate of $0.50 per share but fell shy of the revenue expectation of $540.0 million. Plexus continues to face cut-throat competition in the EMS market, where component shortages and supply chain constraints are increasing operational complexities.
Moreover, Plexus continues to invest in new sites and increasing headcount that may affect profitability in the near term. We maintain our Underperform rating and set a target price of $25.00.
Further, investment in Plexus is expected to generate just 10% over the next 5 years, compared to the peer group average of 11.5%. We therefore believe that downside potential exists.
PLEXUS CORP (PLXS): Free Stock Analysis Report
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment